We are live on ! Find out more
VNRX icon

VolitionRx Ltd
VNRX

17 hedge funds and large institutions have $18.8M invested in VolitionRx Ltd in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

0% more funds holding

Funds holding: 17 → 17 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

0.03% less ownership

Funds ownership: 0.92% → 0.89% (-0.03%)

14% less capital invested

Capital invested by funds: $21.9M → $18.8M (-$3.12M)

Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.42%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
3
Increased
3
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$44.6K
2
Northern Trust
Northern Trust
Illinois
+$38.7K
3
UBS Group
UBS Group
Switzerland
+$15.8K
4
Vanguard Group
Vanguard Group
Pennsylvania
+$10.2K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$2.74K

Top Sellers

Rank Fund Capital Flow
1
LIM
Lagoda Investment Management
New York
-$599K
2
AIM
Acrospire Investment Management
Illinois
-$20K
3
Morgan Stanley
Morgan Stanley
New York
-$4.42K
4
Creative Planning
Creative Planning
Kansas
-$1.33K
Name Holding Trade Value Shares
Change 		Change in
Stake
LIM
1
Lagoda Investment Management
New York
$11.8M -$599K -6,766 -4%
SCA
2
Southpoint Capital Advisors
New York
$3.22M – – –
KCM
3
Knoll Capital Management
Florida
$1.85M – – –
Vanguard Group
4
Vanguard Group
Pennsylvania
$824K +$10.2K +115 +1%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$405K – – –
Morgan Stanley
6
Morgan Stanley
New York
$237K -$4.42K -50 -2%
Northern Trust
7
Northern Trust
Illinois
$91K +$38.7K +437 +63%
GBA
8
Garrison Bradford & Associates
New York
$62K – – –
Royal Bank of Canada
9
Royal Bank of Canada
Ontario, Canada
$56K – – –
Creative Planning
10
Creative Planning
Kansas
$53K -$1.33K -15 -2%
Bank of New York Mellon
11
Bank of New York Mellon
New York
$45K +$2.74K +31 +6%
BlackRock
12
BlackRock
New York
$41K +$44.6K +504 New
Bessemer Group
13
Bessemer Group
New Jersey
$40K – – –
AG
14
Advisor Group
Arizona
$30K – – –
UBS Group
15
UBS Group
Switzerland
$14K +$15.8K +179 New
TRCT
16
Tower Research Capital (TRC)
New York
$2K +$2.21K +25 New
IP
17
Intellectus Partners
California
$1K – – –
AIM
18
Acrospire Investment Management
Illinois
– -$20K -220 Closed

VNRX Hedge Fund Activity: Q1 2017 in Review

17 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in VolitionRx Ltd (VNRX) for Q1 2017, worth a combined $18.8M — down 14% from $21.9M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new VNRX positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 3 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $44.6K. The largest seller was Lagoda Investment Management, cutting an estimated $599K.

  • 17 institutional investors held VolitionRx Ltd (VNRX) as of Q1 2017, unchanged from Q4 2016.
  • Funds reported $18.8M of VolitionRx Ltd stock for Q1 2017, down 14% quarter-over-quarter.
  • 3 funds opened new VolitionRx Ltd positions in Q1 2017 and 1 closed out, a net change of +2 holders.
  • The largest VolitionRx Ltd buyer in Q1 2017 was BlackRock, an estimated $44.6K added.
  • The largest VolitionRx Ltd seller in Q1 2017 was Lagoda Investment Management, an estimated $599K sold.

Based on aggregated 13F filings for Q1 2017.